Cite
Cardiac toxicity of chemotherapy for breast cancer: do angiotensin-converting enzyme inhibitors and beta blockers protect?
MLA
Bisceglia, Irma, et al. “Cardiac Toxicity of Chemotherapy for Breast Cancer: Do Angiotensin-Converting Enzyme Inhibitors and Beta Blockers Protect?” European Heart Journal Supplements : Journal of the European Society of Cardiology, vol. 25, no. Suppl B, Apr. 2023, pp. B25–27. EBSCOhost, https://doi.org/10.1093/eurheartjsupp/suad062.
APA
Bisceglia, I., Mistrulli, R., Cartoni, D., Matera, S., Petrolati, S., & Canale, M. L. (2023). Cardiac toxicity of chemotherapy for breast cancer: do angiotensin-converting enzyme inhibitors and beta blockers protect? European Heart Journal Supplements : Journal of the European Society of Cardiology, 25(Suppl B), B25–B27. https://doi.org/10.1093/eurheartjsupp/suad062
Chicago
Bisceglia, Irma, Raffaella Mistrulli, Domenico Cartoni, Sabrina Matera, Sandro Petrolati, and Maria Laura Canale. 2023. “Cardiac Toxicity of Chemotherapy for Breast Cancer: Do Angiotensin-Converting Enzyme Inhibitors and Beta Blockers Protect?” European Heart Journal Supplements : Journal of the European Society of Cardiology 25 (Suppl B): B25–27. doi:10.1093/eurheartjsupp/suad062.